You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Patent: 9,518,123

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,518,123

Title:	Compositions and methods for treatment of cancer
Abstract:	The present invention provides compositions and methods for treating cancer in a human. The invention includes relates to administering a genetically modified T cell to express a CAR wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a CD3 zeta signaling domain.
Inventor(s):	June; Carl H. (Merion Station, PA), Levine; Bruce L. (Cherry Hill, NJ), Porter; David L. (Springfield, PA), Kalos; Michael D. (Philadelphia, PA), Milone; Michael C. (Cherry Hill, NJ)
Assignee:	The Trustees of the University of Pennsylvania (Philadelphia, PA)
Application Number:	14/997,042
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,518,123
Patent Claims:	see list of patent claims

Details for Patent 9,518,123

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genzyme Corporation	CAMPATH	alemtuzumab	Injection	103948	05/07/2001	⤷ Try a Trial	2030-12-09
Genzyme Corporation	LEMTRADA	alemtuzumab	Injection	103948	11/14/2014	⤷ Try a Trial	2030-12-09
Genzyme Corporation	CAMPATH	alemtuzumab	Injection	103948	10/12/2004	⤷ Try a Trial	2030-12-09
Genentech, Inc.	RAPTIVA	efalizumab	Injection	125075	10/27/2003	⤷ Try a Trial	2030-12-09
Biogen Inc.	TYSABRI	natalizumab	Injection	125104	11/23/2004	⤷ Try a Trial	2030-12-09
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.